Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Propofol emulsion and bacterial contamination

G J McHugh1, G M Roper

  • 1Department of Anaesthesia, Memorial Hospital, Hastings, New Zealand.

Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie
|September 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fatal vitamin C-associated acute renal failure.

Anaesthesia and intensive care·2008
Same author

Paediatric intensive care in non-paediatric ICUs.

Anaesthesia and intensive care·2008
Same author

Paediatric admissions to the general intensive care unit at palmerston north hospital.

Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine·2006
Same author

Development of audit and quality assurance in an intensive care unit. A smaller hospital perspective.

Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine·2006
Same author

Informed consent and the incompetent adult patient in intensive care--a New Zealand perspective.

Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine·2006
Same author

Quality and reliability of data collected in a regional hospital intensive care unit.

Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine·2006

Propofol (anesthetic) can remain bacteriologically safe despite delays in administration. Prompt administration is advised, but standard clinical conditions allow for some delay without increased bacterial contamination risk.

Area of Science:

  • Anesthesiology
  • Microbiology
  • Clinical Pharmacy

Background:

  • Package inserts for propofol recommend immediate administration after preparation.
  • Concerns exist regarding bacterial contamination of propofol with prolonged delays.
  • Understanding contamination risks is crucial for patient safety in anesthesia.

Purpose of the Study:

  • To investigate delays between propofol preparation and administration in clinical settings.
  • To determine the incidence of bacterial contamination under these delayed conditions.
  • To assess the relationship between administration delays and microbial growth in propofol.

Main Methods:

  • Prospective examination of 254 clinical administrations of propofol.
  • Measurement of time intervals from propofol drawing-up to induction and induction to culture inoculation.

Related Experiment Videos

  • Bacterial culture of propofol samples to assess contamination.

    • Main Results:

    • Mean delay from drawing-up to induction was 28.8 minutes; 68.5% of cases exceeded 10 minutes.
    • Mean delay from induction to culture inoculation was 11.6 minutes.
    • Bacterial contamination was found in 6.3% of cultures; delay to induction did not increase contamination risk.
    • Increased delay between induction and culture inoculation correlated with higher odds of bacterial growth.

    Conclusions:

    • Propofol can be bacteriologically safe for use even with inadvertent administration delays under standard clinical conditions.
    • Contamination is more likely to occur during or after induction, emphasizing the need for asepsis.
    • While prompt administration is advised, findings support the safety of propofol use despite typical clinical delays.